The simultaneous open-market sales by the CEO, CFO, CCO, and CLO on the same day (June 9) is an unusually coordinated signal. While the dollar amount is modest, the breadth of C-suite participation warrants caution. Monitor for any upcoming news (earnings, pipeline update, financing) that may have prompted this cluster. The cross-filing calibration amplifies this cluster's significance.
ABEO drugs
ABEO drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Jun 16 $5.65entry
- T+1 · 5mo ago 0.00%α +1.25% · $5.65
- T+5 · 5mo ago +1.24%α +3.47% · $5.72
- T+20 · 4mo ago +24.96%α +24.76% · $7.06
- T+60 · due 2mo ago Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Five ABEO insiders, including the CEO and CFO, sold a total of $407K in open-market sales over a 7-day window. The cluster is concentrated on June 9, with the CEO alone selling $169K. While the dollar amount is modest relative to the $315M market cap (0.13%), the participation of the entire C-suite (CEO, CFO, CCO, CLO) on the same day is notable and amplifies the signal per the cross-filing calibration.
Key Financial Metrics
Key Facts
- CEO Vishwas Seshadri sold 31,916 shares for $169K on June 9.
- CFO Joseph Vazzano sold 13,421 shares for $71K on June 9.
- CCO Madhav Vasanthavada sold 5,450 shares for $29K on June 9.
- CLO Brendan O'Malley sold 6,305 shares for $33K on June 9.
- Director Christine Silverstein sold 18,160 shares for $104K on June 15.
- Total cluster value: $407K, representing 0.13% of market cap.
- All sales were open-market (code S); no 10b5-1 plan context provided.
Financial Impact
Total insider sales of $407K, or 0.13% of $315M market cap.
Risk Factors
- Potential negative catalyst (e.g., clinical trial setback, financing need) that insiders may be anticipating.
- Further insider selling could pressure the stock.
- Lack of 10b5-1 plan disclosure increases the likelihood of discretionary, potentially informed, selling.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ABEO-1781567345178 |
Track record
29 reports on ABEO
4 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +15.24% at T+20 after the Sep 29, 2026 report. 4 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $2.59 Now $2.60 +0.39% settles Nov 18
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $2.30 Now $2.60 +13.04% settles Nov 17
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $2.29 to $2.42 Now $2.60 +13.54% ▲ +5.68% +6.04% vs SPY
- Nov 9, 20267d ago Press Release Neutral 5/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
- Nov 9, 20267d ago 8-K Bearish 6/10 Entry $2.54 to $2.46 Now $2.60 −2.36% ▲ +3.35% +2.98% vs SPY
- Nov 9, 20267d ago Press Release Mixed 6/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $4.17 to $2.54 Now $2.60 −37.65% ▼ −39.09% −41.46% vs SPY
- Oct 23, 202624d ago SC 13D Bullish 6/10 Entry $4.40 to $4.31 Now $2.60 −40.91% ▼ −2.05% −2.76% vs SPY
- Sep 29, 20266w ago Insider Cluster Bearish 4/10 Entry $5.25 to $5.01 Now $2.60 +50.48% ▲ +4.57% +4.75% vs SPY
- Sep 18, 20268w ago Press Release Bullish 6/10 Entry $5.57 to $5.67 Now $2.60 −53.32% ▲ +1.80% +0.24% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers